The Biomedical Sciences Industry Partnership Office (BMSIPO) serves as the national office dedicated to driving technology‑business public‑private R&D partnerships with strategic biomedical sciences and healthcare companies. These include multinational pharmaceutical, biotech, diagnostics, digital health and medtech companies, as well as innovative local enterprises.

BMSIPO engages and account‑manages companies strategic to Singapore, and architects R&D partnerships from early discovery and pre‑clinical development, translational clinical development, to manufacturing R&D, across the diverse public sector research and clinical institutions in Singapore.

BMSIPO develops and executes industry development strategies for key publicly‑funded research and clinical R&D programmes of national priority, including National Platforms, and multi‑institutional...